Suchitra Uppicherla, Divya Sree Tadimarri, Nandha Kumar K. N., Haritha Rajaboyna, K. D. Yadavendra Reddy, Gowtham Kumar Reddy Ponnolu, Rajaram Cuddapah, Jeevan Kumar B.
{"title":"评价三级护理教学医院他汀类药物的使用:一项观察性前瞻性研究，YSR Kadapa","authors":"Suchitra Uppicherla, Divya Sree Tadimarri, Nandha Kumar K. N., Haritha Rajaboyna, K. D. Yadavendra Reddy, Gowtham Kumar Reddy Ponnolu, Rajaram Cuddapah, Jeevan Kumar B.","doi":"10.53411/jpadr.2023.4.2.5","DOIUrl":null,"url":null,"abstract":"ABSTRACT;\nIntroduction: Statins are highly preferred drugs in the treatment and prevention of atherosclerotic diseases. Statins usage increased in the last two decades. DUE is a cyclic quality-enhancing procedure in the prescription of drugs. Methods: Our study engaged in compiling various prescribing conditions for statins, assessing their effectiveness and safety, and comparing the lipid profile images of atorvastatin and rosuvastatin. A prospective observational study with the involvement of 150 volunteers The complete data collected is analysed using SAS and Microsoft Excel software. Statistical methods of mean, standard deviation, clinical significance, and Z value are calculated.\nResults: Atorvastatin (20 mg, 40 mg, and 80 mg) and Rosuvastatin (5 mg and 10mg) are widely used in the primary, secondary, and tertiary prevention of atherosclerotic cardiovascular and cerebrovascular problems. Average reduction of LDL and total cholesterol levels to 106.5(SD ±11.04) and 203.53 (SD±94) respectively.\nKey words: Atorvastatin, cardiovascular and cerebrovascular problems, non\nadherence, Re-occurrence, Rosuvastatin.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of statin utilisation in tertiary care teaching hospital: An observational prospective study, YSR Kadapa\",\"authors\":\"Suchitra Uppicherla, Divya Sree Tadimarri, Nandha Kumar K. N., Haritha Rajaboyna, K. D. Yadavendra Reddy, Gowtham Kumar Reddy Ponnolu, Rajaram Cuddapah, Jeevan Kumar B.\",\"doi\":\"10.53411/jpadr.2023.4.2.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT;\\nIntroduction: Statins are highly preferred drugs in the treatment and prevention of atherosclerotic diseases. Statins usage increased in the last two decades. DUE is a cyclic quality-enhancing procedure in the prescription of drugs. Methods: Our study engaged in compiling various prescribing conditions for statins, assessing their effectiveness and safety, and comparing the lipid profile images of atorvastatin and rosuvastatin. A prospective observational study with the involvement of 150 volunteers The complete data collected is analysed using SAS and Microsoft Excel software. Statistical methods of mean, standard deviation, clinical significance, and Z value are calculated.\\nResults: Atorvastatin (20 mg, 40 mg, and 80 mg) and Rosuvastatin (5 mg and 10mg) are widely used in the primary, secondary, and tertiary prevention of atherosclerotic cardiovascular and cerebrovascular problems. Average reduction of LDL and total cholesterol levels to 106.5(SD ±11.04) and 203.53 (SD±94) respectively.\\nKey words: Atorvastatin, cardiovascular and cerebrovascular problems, non\\nadherence, Re-occurrence, Rosuvastatin.\",\"PeriodicalId\":388338,\"journal\":{\"name\":\"Journal of Pharmacovigilance and Drug Research\",\"volume\":\"10 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacovigilance and Drug Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53411/jpadr.2023.4.2.5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacovigilance and Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53411/jpadr.2023.4.2.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of statin utilisation in tertiary care teaching hospital: An observational prospective study, YSR Kadapa
ABSTRACT;
Introduction: Statins are highly preferred drugs in the treatment and prevention of atherosclerotic diseases. Statins usage increased in the last two decades. DUE is a cyclic quality-enhancing procedure in the prescription of drugs. Methods: Our study engaged in compiling various prescribing conditions for statins, assessing their effectiveness and safety, and comparing the lipid profile images of atorvastatin and rosuvastatin. A prospective observational study with the involvement of 150 volunteers The complete data collected is analysed using SAS and Microsoft Excel software. Statistical methods of mean, standard deviation, clinical significance, and Z value are calculated.
Results: Atorvastatin (20 mg, 40 mg, and 80 mg) and Rosuvastatin (5 mg and 10mg) are widely used in the primary, secondary, and tertiary prevention of atherosclerotic cardiovascular and cerebrovascular problems. Average reduction of LDL and total cholesterol levels to 106.5(SD ±11.04) and 203.53 (SD±94) respectively.
Key words: Atorvastatin, cardiovascular and cerebrovascular problems, non
adherence, Re-occurrence, Rosuvastatin.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
